SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000926617-20-000052
Filing Date
2020-07-07
Accepted
2020-07-06 17:42:05
Documents
4
Period of Report
2020-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K awh-20200706x8k.htm 8-K 53384
2 EX-10.1 awh-20200706xex10_1.htm EX-10.1 270545
3 EX-99.1 awh-20200706xex99_1.htm EX-99.1 17242
4 GRAPHIC awh-20200706xex99_1g001.jpg GRAPHIC 135062
  Complete submission text file 0000926617-20-000052.txt   528848
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 201014451
SIC: 2835 In Vitro & In Vivo Diagnostic Substances